NORTHBROOK, Ill.–(BUSINESS WIRE)–IDEX CORPORATION (NYSE:IEX) today announced that its Board of Directors has approved a regular quarterly cash dividend of $0.73 per common share. This dividend will be paid October 16, 2026 to shareholders of record as of October 2, 2026. This dividend represents the company’s 128th consecutive regular quarterly cash dividend payment. About IDEX IDEX Corporation (NYSE: IEX), a global engineered products company, is comprised of three primary business segments
Author: sHq_LoGiNz
LOS ANGELES–(BUSINESS WIRE)—- $BEAM–BEAM Investors Have Opportunity to Join Beam Therapeutics Inc. Fraud Investigation with SBS Law
LOS ANGELES–(BUSINESS WIRE)—- $BEAM–BEAM Investors Have Opportunity to Join Beam Therapeutics Inc. Fraud Investigation with SBS Law
LOS ANGELES–(BUSINESS WIRE)—- $BEAM–BEAM Investors Have Opportunity to Join Beam Therapeutics Inc. Fraud Investigation with SBS Law
CULLMAN, Ala.–(BUSINESS WIRE)–Enclave launches a new DST offering backed by a fully leased Alabama industrial asset, seeking $9.3 million from accredited 1031 exchange investors.
CULLMAN, Ala.–(BUSINESS WIRE)–Enclave launches a new DST offering backed by a fully leased Alabama industrial asset, seeking $9.3 million from accredited 1031 exchange investors.
CULLMAN, Ala.–(BUSINESS WIRE)–Enclave launches a new DST offering backed by a fully leased Alabama industrial asset, seeking $9.3 million from accredited 1031 exchange investors.
LOS ANGELES–(BUSINESS WIRE)—- $PHAT–PHAT Investors Have Opportunity to Join Phathom Pharmaceuticals, Inc. Fraud Investigation with SBS Law
LOS ANGELES–(BUSINESS WIRE)—- $PHAT–PHAT Investors Have Opportunity to Join Phathom Pharmaceuticals, Inc. Fraud Investigation with SBS Law
LOS ANGELES–(BUSINESS WIRE)—- $PHAT–PHAT Investors Have Opportunity to Join Phathom Pharmaceuticals, Inc. Fraud Investigation with SBS Law
